Fludarabin Accord 25 mg/ml, Konzentrat zur Herstellung einer Injektions- /Infusionslösung
7680667500018
CH-66750
Konzentrat
Associated product:
FLUDARABIN Accord conc perf 50 mg/2ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
16.15 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 163.70
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2019
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66750
- Drug name
- Fludarabin Accord, Konzentrat zur Herstellung einer Injektions-/Infusionslösung
- Galenic form
- KOIN
- ATC Code
- L01BB05
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 15/08/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- FLUDARABIN Accord conc perf 50 mg/2ml flac
- Description (DE)
- FLUDARABIN Accord Inf Konz 50 mg/2ml Durchstf
- Market launch
- 15/08/2018
- Narcotic (BTM)
- No